To include your compound in the COVID-19 Resource Center, submit it here.

Metadoxine ER: Phase III hold

FDA placed a full clinical hold on metadoxine ER to treat ADHD and fragile X syndrome, which

Read the full 170 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE